Search Results - "Robeson, A"

Refine Results
  1. 1

    Fatty acid synthase inhibition engages a novel caspase-2 regulatory mechanism to induce ovarian cancer cell death by Yang, C-S, Matsuura, K, Huang, N-J, Robeson, A C, Huang, B, Zhang, L, Kornbluth, S

    Published in Oncogene (18-06-2015)
    “…Blockade of fatty acid synthase (FASN), a key enzyme involved in de novo lipogenesis, results in robust death of ovarian cancer cells. However, known FASN…”
    Get full text
    Journal Article
  2. 2

    The deubiquitinating enzyme DUBAI stabilizes DIAP1 to suppress Drosophila apoptosis by Yang, C-S, Sinenko, S A, Thomenius, M J, Robeson, A C, Freel, C D, Horn, S R, Kornbluth, S

    Published in Cell death and differentiation (01-04-2014)
    “…Deubiquitinating enzymes (DUBs) counteract ubiquitin ligases to modulate the ubiquitination and stability of target signaling molecules. In Drosophila , the…”
    Get full text
    Journal Article
  3. 3

    Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome by Stover, D E, White, D A, Romano, P A, Gellene, R A, Robeson, W A

    Published in The American journal of medicine (01-03-1985)
    “…Over a four-year period, 130 patients with the acquired immune deficiency syndrome were studied to assess the incidence and spectrum of pulmonary disease…”
    Get more information
    Journal Article
  4. 4
  5. 5
  6. 6

    Significance of Academic Merit, Test Scores, Interviews and the Admissions Process: A Case Study by Hardigan, Patrick C, Lai, L. Leanne, Arneson, Dean, Robeson, Andrew

    “…The purpose of this study was to offer a model for admissions to pharmacy colleges not using a weighted average formula and to test its consistency and…”
    Get more information
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Cost-effectiveness of screening for hereditary hemochromatosis by Phatak, P D, Guzman, G, Woll, J E, Robeson, A, Phelps, C E

    Published in Archives of internal medicine (1960) (11-04-1994)
    “…Recent studies have estimated the prevalence of hereditary hemochromatosis to be 3 to 8 per 1000. Early detection and treatment can prevent disease…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20